| Date Checked | 2026-02-19 22:17:47 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | 2018-06-11 |
| Symbol | IBIO |
| AssetType | Common Stock |
| Name | iBio, Inc. Common Stock |
| Description | iBio, Inc. is a pioneering biotechnology firm based in New York, dedicated to advancing plant-based biopharmaceutical production. The company offers specialized contract development and manufacturing services for biologics, including vaccines and therapeutics, establishing itself as a key player in both domestic and international markets. With its proprietary technologies, iBio enhances the efficiency and scalability of biologics manufacturing, addressing the increasing demand for sustainable and economically viable solutions in the evolving life sciences sector. Through innovation and strategic partnerships, iBio is positioned to contribute significantly to the future of healthcare. |
| CIK | 1420720 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 11750 SORRENTO VALLEY ROAD, SAN DIEGO, CA, UNITED STATES, 92121 |
| OfficialSite | https://ibioinc.com |
| FiscalYearEnd | June |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 52845000 |
| EBITDA | -19669000 |
| PERatio | 0 |
| PEGRatio | 0 |
| BookValue | 2.767 |
| DividendPerShare | None |
| EPS | -1.4 |
| RevenuePerShareTTM | 0.038 |
| ProfitMargin | 0 |
| OperatingMarginTTM | -59.51 |
| ReturnOnAssetsTTM | -0.288 |
| ReturnOnEquityTTM | -0.545 |
| RevenueTTM | 500000 |
| GrossProfitTTM | 500000 |
| DilutedEPSTTM | -1.4 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | 0.143 |
| AnalystTargetPrice | 4.767 |
| AnalystRatingStrongBuy | 0 |
| AnalystRatingBuy | 6 |
| AnalystRatingHold | 0 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | 105.69 |
| PriceToBookRatio | 0.943 |
| EVToRevenue | 13.11 |
| EVToEBITDA | -1.589 |
| Beta | 1.149 |
| 52WeekHigh | 6.89 |
| 52WeekLow | 0.56 |
| 50DayMovingAverage | 1.574 |
| 200DayMovingAverage | 1.189 |
| SharesOutstanding | 22487300 |
| SharesFloat | 15259400 |
| PercentInsiders | 3.559 |
| PercentInstitutions | 55.782 |
| ExDividendDate | None |
| naga | 0 |
| etoro | 0 |
| dateChecked | 2026-02-19 22:17:47 |
| fresh | 1 |